Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Stroke

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.31.7.1686PMID 10884474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel and Efficient Synthesis of a Highly Active Analogue of clasto-Lactacystin β-Lactone.

  2000cited by this paper
• Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.

  2000cited by this paper
• Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia

  2000cited by this paper
• Insulin-Like Growth Factor Binding Proteins: New Proteins, New Functions

  1999cited by this paper
• Protein kinase C–dependent activation of NF-κB in enterocytes is independent of IκB degradation

  1999cited by this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke

  1999cited by this paper
• A NOVEL AND EFFICIENT SYNTHESIS OF A HIGHLY ACTIVE ANALOGUE OF CLASTO-LACTACYSTIN BETA -LACTONE

  1999cited by this paper
• NF-κB is activated and promotes cell death in focal cerebral ischemia

  1999cited by this paper
• Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

  1999cited by this paper
• Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.

  1999cited by this paper
• Proteasome inhibition: A novel mechanism to combat asthma.

  1999cited by this paper
• Protein kinase C-dependent activation of NF-kappaB in enterocytes is independent of IkappaB degradation.

  1999cited by this paper
• NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

  1999cited by this paper
• A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry.

  1998cited by this paper
• Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives.

  1998cited by this paper
• Traumatic spinal cord injury induces nuclear factor-kappaB activation.

  1998cited by this paper
• Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats.

  1998cited by this paper
• Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.

  1998cited by this paper
• tPA in acute ischemic stroke

  1998cited by this paper
• Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation

  1998cited by this paper
• A Critical Reevaluation of the Intraluminal Thread Model of Focal Cerebral Ischemia

  1998cited by this paper
• Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.

  1997cited by this paper
• -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.

  1997cited by this paper
• Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model

  1997cited by this paper
• Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis.

  1997cited by this paper
• Short Therapeutic Window for MK-801 in Transient Focal Cerebral Ischemia in Normotensive Rats

  1996cited by this paper
• Tyrosine Phosphorylation of I?B-a Activates NF-?B without Proteolytic Degradation of I?B-a

  1996cited by this paper
• Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

  1996cited by this paper
• Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

  1996cited by this paper
• Emerging treatments for stroke in humans.

  1996cited by this paper
• An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

  1996cited by this paper
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

  1996cited by this paper
• The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression.

  1995cited by this paper
• Induced Expression of Adhesion Molecules Following Focal Brain Ischemia

  1995cited by this paper
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia.

  1995cited by this paper
• Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.

  1995cited by this paper
• Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons.

  1995cited by this paper
• Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.

  1995cited by this paper
• Quinolinic acid accumulation and functional deficits following experimental spinal cord injury.

  1995cited by this paper
• Correlation Between Myeloperoxidase‐Quantified Neutrophil Accumulation and Ischemic Brain Injury in the Rat: Effects of Neutrophil Depletion

  1994cited by this paper
• The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

  1994cited by this paper
• Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat.

  1994cited by this paper
• Postischemic Administration of an Anti‐Mac‐1 Antibody Reduces Ischemic Cell Damage After Transient Middle Cerebral Artery Occlusion in Rats

  1994cited by this paper
• Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat.

  1993cited by this paper
• Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia

  1992cited by this paper
• Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization

  1992cited by this paper
• Induction of Interleukin‐1β mRNA in Rat Brain After Transient Forebrain Ischemia

  1992cited by this paper
• Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia.

  1992cited by this paper
• Background review and current concepts of reperfusion injury.

  1990cited by this paper

• The immunoproteasome as a neuroimmune hub in the central nervous system: from proteostasis stress to inflammatory pathology.

  2026cites this paper
• Neuroprotection by Post-Stroke Administration of the Slow-Releasing Hydrogen Sulfide (H2S) Donor AP39: Long-Term Functional, MRI, and Molecular Evidence in a Rodent Stroke Model.

  2025cites this paper
• Selenium pretreatment improve renal function, autophagy signaling pathway and mir21a gene expression in renal ischemia reperfusion injury model in male rat.

  2025cites this paper
• Targeting PTGS2/NF-κB Pathway: MG-132's Role in Reducing Ischemic Stroke Injury.

  2025cites this paper
• Preferential Synaptic Type of GABA-A Receptor Ligands Enhancing Neuronal Survival and Facilitating Functional Recovery After Ischemic Stroke.

  2024cites this paper
• Pretreatment with sodium selenite alleviates inflammatory responses in renal ischemia-reperfusion injury by suppressing the expression of NF-κb and miR-494

  2024cites this paper
• BAG3 Overexpression Attenuates Ischemic Stroke Injury by Activating Autophagy and Inhibiting Apoptosis

  2023cites this paper
• Estimation of Chaos and Coherence in Frontoparietal, Occipital and Temporal Lobes at Pre, Post and During Focal Cerebral Ischemia

  2022cites this paper
• Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke

  2022cites this paper
• The Proteostasis Network: A Global Therapeutic Target for Neuroprotection after Spinal Cord Injury

  2022cites this paper
• Pathological changes of brain oscillations following ischemic stroke

  2022cites this paper
• The effects of adenosine injection after of brain ischemia reperfusion injury on gene expression of NF-kB/p65 and activity level of ROS in hippocampus tissue of male wistar rats

  2022cites this paper
• The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia

  2021cites this paper
• Inhibition of Fatty Acid Synthesis Aggravates Brain Injury, Reduces Blood-Brain Barrier Integrity and Impairs Neurological Recovery in a Murine Stroke Model

  2021cites this paper
• The effects of adenosine injection after of brain ischemia reperfusion injury on gene expression of NF-kB/p65 and activity level of ROS in hippocampus tissue of male wistar rats

  2020cites this paper
• اثر تزریق آدنوزین پس از ایسکمی ریپرفیوژن مغزی بر بیان ژن NF-kB/p65 و سطح فعالیت ROS بافت هیپوکامپ مغز در موشهای نر ویستار

  2020cites this paper
• Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia

  2020cites this paper
• Lithium modulates miR‐1906 levels of mesenchymal stem cell‐derived extracellular vesicles contributing to poststroke neuroprotection by toll‐like receptor 4 regulation

  2020cites this paper
• اثر تزریق آدنوزین پس از ایسکمی ریپرفیوژن مغزی بر بیان ژن NF-kB/p65 و سطح فعالیت ROS بافت هیپوکامپ مغز در موشهای نر ویستار

  2019cites this paper
• Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases

  2019cites this paper
• Evidence that melatonin downregulates Nedd4-1 E3 ligase and its role in cellular survival.

  2019cites this paper
• Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury

  2017cites this paper
• Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury

  2017cites this paper
• Proteasome and Organs Ischemia-Reperfusion Injury

  2017cites this paper
• Innate Immune Response in Kidney Ischemia/Reperfusion Injury: Potential Target for Therapy

  2017cites this paper
• N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression

  2016cites this paper
• Acute energy deprivation in isolated neurons and tumor stem cells. Effects on intracellular calcium and mitochondrial function

  2016cites this paper
• The proteasome - victim or culprit in autoimmunity.

  2016cites this paper
• [Significance of increased and reduced proteasome activity in the pathomechanism of selected disorders].

  2016cites this paper
• Application of SPR Imaging Biosensor for the Measurement of 20S Proteasomes in Blood Plasma of Children with Thermal Injury.

  2016cites this paper
• Ischemic Post-Conditioning Induces Post-Stroke Neuroprotection via Hsp70-Mediated Proteasome Inhibition and Facilitates Neural Progenitor Cell Transplantation

  2016cites this paper
• Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations

  2016cites this paper
• Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood–Brain–Barrier Integrity

  2015cites this paper
• Toll‐like receptor‐4 knockout mice are more resistant to optic nerve crush damage than wild‐type mice

  2015cites this paper
• Proteasomal activity in brain tissue following ischemic stroke in Wistar rats.

  2015cites this paper
• The comparison of C-proteasome activity in the plasma of children after burn injury, mild head injury and blunt abdominal trauma.

  2015cites this paper
• Proteasome inhibitors: possible novel therapeutic strategy for ischemia–reperfusion injury?

  2014cites this paper
• Present status and future challenges of electroencephalography- and magnetic resonance imaging-based monitoring in preclinical models of focal cerebral ischemia.

  2014cites this paper
• Quantitative proteomics reveals differential biological processes in healthy neonatal cord neutrophils and adult neutrophils

  2014cites this paper
• Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?

  2014influential citation
• Original Article Suppression of inflammatory response by flurbiprofen following focal cerebral ischemia involves the NF-κB signaling pathway

  2014cites this paper
• Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.

  2014cites this paper
• Inflammation and White Matter Injury in Animal Models of Ischemic Stroke

  2014cites this paper
• Suppression of inflammatory response by flurbiprofen following focal cerebral ischemia involves the NF-κB signaling pathway.

  2014cites this paper
• Habilitationsschrift Molekulare Grundlagen der protektiven Effekte von Proteasominhibitoren im kardiovaskulären System

  2013cites this paper
• MyD88 Is a Critical Regulator of Hematopoietic Cell-Mediated Neuroprotection Seen after Stroke

  2013cites this paper
• Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.

  2013cites this paper
• Molekulare Grundlagen der protektiven Effekte von Proteasominhibitoren im kardiovaskulären System

  2013cites this paper
• Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury

  2012cites this paper
• Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB

  2012cites this paper
• Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice.

  2012cites this paper
• The proteasome in health and disease.

  2012cites this paper
• Ischaemic Postconditioning Rescues Brain Injury Caused by Focal Ischaemia/Reperfusion via Attenuation of Protein Oxidization

  2012cites this paper
• Proteasome Inhibitor Reduces Astrocytic iNOS Expression and Functional Deficit after Experimental Intracerebral Hemorrhage in Rats

  2012cites this paper
• The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis.

  2012cites this paper
• Neuroprotection of Tanshinone IIA against Cerebral Ischemia/Reperfusion Injury through Inhibition of Macrophage Migration Inhibitory Factor in Rats

  2012cites this paper
• Protein Oxidation in Some Age‐Related Diseases

  2012cites this paper
• Therapeutic window of taurine against experimental stroke in rats.

  2012cites this paper
• Ischemic Postconditioning Protects Neuronal Death Caused by Cerebral Ischemia and Reperfusion via Attenuating Protein Aggregation

  2012cites this paper
• Differential regulation of Nedd4 ubiquitin ligases and their adaptor protein Ndfip1 in a rat model of ischemic stroke.

  2012cites this paper
• Up‐regulation of endoplasmic reticulum stress‐related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin

  2011cites this paper
• Der Einfluss des Proteasominhibitors Bortezomib auf die kardiale Hypertrophie in der Dahl Salz-sensitiven Ratte

  2011cites this paper
• Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.

  2011cites this paper
• Reviewy treatment strategies for ischemia/reperfusion injury in transplantation

  2010cites this paper
• Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation

  2010cites this paper
• Role of the Proteasome in Excitotoxicity-Induced Cleavage of Glutamic Acid Decarboxylase in Cultured Hippocampal Neurons

  2010cites this paper
• The proteasome ubiquitin system as a drug target in cerebrovascular disease: The therapeutic potential of proteasome inhibitors

  2010cites this paper
• Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action.

  2010cites this paper
• Antiplasmodiale Thiostreptonderivate – Proteasominhibitoren mit einem dualen Wirkmechanismus

  2010cites this paper
• Neuroprotection antiinflammatoire et antiischémique par modulation du protéasome

  2010cites this paper
• Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation.

  2010cites this paper
• Elevation of heme oxygenase‐1 by proteasome inhibition affords dopaminergic neuroprotection

  2010cites this paper
• Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS?

  2010cites this paper
• Searching for NF-kappaB-based treatments of ischemia reperfusion injury.

  2009cites this paper
• Modeling cerebral ischemia in neuroproteomics.

  2009cites this paper
• Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat

  2009cites this paper
• Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.

  2009cites this paper
• Protective effect of docosahexaenoic acid against brain injury in ischemic rats.

  2009influential citation
• Systemic Administration of Proteasome Inhibitor Protects Against MPTP Neurotoxicity in Mice

  2009cites this paper
• The preventive effect of mexiletine on cerebral ischemic injury following experimental middle cerebral artery occlusion.

  2009cites this paper
• The proteasomal system.

  2009cites this paper
• Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury.

  2009cites this paper
• The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.

  2009cites this paper
• Searching for NF-κB-Based Treatments of Ischemia Reperfusion Injury

  2009influential citation
• The effects of glucose on proteasome activities in neuronal cells under in vitro ischemia conditions

  2009cites this paper
• The methodology of neuroproteomics.

  2009cites this paper
• PROTEASOME PEPTIDASE ACTIVITIES PARALLEL HISTOMORPHOLOGICAL AND FUNCTIONAL CONSEQUENCES OF ISCHEMIA-REPERFUSION INJURY IN THE LUNG

  2009cites this paper
• Bmc Complementary and Alternative Medicine Neuroprotective Efficacy and Therapeutic Window of Curcuma Oil: in Rat Embolic Stroke Model

  2008cites this paper
• In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma

  2008cites this paper
• Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.

  2008cites this paper
• The Proteasome: A Target of Oxidative Damage in Cultured Human Retina Pigment

  2008cites this paper
• Proteasome inhibitors: Poisons and remedies

  2008cites this paper
• Preconditioning reprograms TLR signaling following cerebral ischemia the emergence of a neuroprotective program

  2008cites this paper
• Joining the army of proteasome inhibitors.

  2008cites this paper
• Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury

  2008cites this paper
• The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.

  2008cites this paper
• Proteasome Inhibitor Does Not Enhance MPTP Neurotoxicity in Mice

  2008cites this paper
• The ubiquitin-proteasome system: A novel target for anticancer and anti-inflammatory drug research

  2008cites this paper
• The proteasome inhibitor bortezomib inhibits intimal hyperplasia of autologous vein grafting in rat model.

  2008cites this paper
• Failure of acute administration with proteasome inhibitor to provide a model of Parkinson’s disease in mice

  2008cites this paper